• Recipharm Signs Manufacturing Deal with Enzymatica contractpharma
    January 22, 2021
    ​Recipharm, a contract development and manufacturing organization (CDMO), and Enzymatica, a Swedish life science company specializing in products with a protective barrier, have signed a broadened contract for the manufacture of ColdZyme.
PharmaSources Customer Service